Update on treatment strategies for bleb-associated endophthalmitis.
OBJECTIVE
Visual preservation in the setting of bleb-associated endophthalmitis has been difficult with existing management strategies. In this article, established findings are compared and potential new treatments that may improve visual outcomes in bleb-associated endophthalmitis are evaluated.


RESULTS
Recent reports have contributed to the existing database of results from bleb-associated endophthalmitis. New systemic antibiotics and novel surgical techniques are also described.


CONCLUSIONS
More options are now available to treat bleb-associated endophthalmitis. No one treatment paradigm is definitively superior in producing desired visual outcomes.
Busbee
Brandon G
BG
Retina Vitreous Associates, Nashville, Tennessee, USA.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001768:Blister / Q000150:complications*; D003131:Combined Modality Therapy; D009877:Endophthalmitis / Q000209:etiology / Q000628:therapy*; D018463:Filtering Surgery / Q000009:adverse effects*; D006801:Humans; D014821:Vitrectomy
D000890:Anti-Infective Agents